Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
King Pharmaceuticals has decided to discontinue manufacturing Intal nebulizer solution (cromolyn sodium inhalation solution). The decision is based upon many factors, including the company’s ...
Gilead Sciences Submits Marketing Authorisation Application for Aztreonam Lysine 75 mg Powder for Nebuliser Solution, a Potential New Treatment for Cystic Fibrosis, to European Medicines Agency FOSTER ...
Statistically Significant Improvement in Percent Predicted Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) Versus Placebo at Week 24 (Primary Endpoint) and Week 48 (Secondary Endpoint) ...
Savara (SVRA) announced the European Patent Office has issued patent No. 4 496 611 titled, “Drug-Device Combination Comprising a Liquid Solution ...
(MENAFN- EIN Presswire) FREDERICK, MD, UNITED STATES, June 30, 2025 /EINPresswire / -- Adam DME, a leader in durable medical equipment, is transforming respiratory therapy with its latest innovation: ...
The nebulizer solution imported from Pakistan to be used for the prevailing influenza was contaminated and could pose more dangers to users, the Government Medical Officers’ Association (GMOA) charged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback